40350-83-2

Basic information

• Product Name: 4-Benzyloxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester
• Synonyms: 4-Benzyloxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester;(4R)-4-(benzyloxy)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid;4-(benzyloxy)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid
• CAS NO: 40350-83-2
• Molecular Formula: C₁₇H₂₃NO₅
• Molecular Weight: 321.36822
• Mol File: 40350-83-2.mol
• Article Data: 16

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-Benzyloxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Benzyloxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester(40350-83-2)
• EPA Substance Registry System: 4-Benzyloxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester(40350-83-2)

Safety Data

• Hazardous Substances Data: 40350-83-2(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 51-35-4 4R-4-hydroxyproline 
• 34619-03-9 tert-butyldicarbonate 
• 100-39-0 benzyl bromide 
• 13726-69-7 (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid 
• 74844-91-0 (2S,4S)-N-tert-butoxycarbonyl-4-hydroxyproline methyl ester 
• 1332341-02-2 benzyl (2S)-2-Boc-amino-3-(2-oxiranyl)propionate 
• 87250-97-3 2’-methyl-2’-propanyl (1S,4S)-3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate 
• 87691-27-8 N-tert-butoxycarbonyl-L-cis-4-hydroxyproline 
• 152892-83-6 (2S,4S)-2-benzyl 1-tert-butyl 4-(benzyloxy)pyrrolidine-1,2-dicarboxylate 
• 262843-21-0 (2S,4S)-1-tert-butyl 2-methyl 4-(benzyloxy)pyrrolidine-1,2-dicarboxylate 
• 1499-56-5 (R)-4-hydroxy-L-proline ethyl ester 
• 136024-60-7 1-(tert-butyl) 2-methyl (2S,4R)-4-(benzyloxy)pyrrolidine-1,2-dicarboxylate 
• 74844-91-0 1-tert-butyl 2-methyl (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate 

Downstream Products

• 40350-84-3 O-benzyl-trans-4-hydroxy-L-proline 
• 865303-03-3 (2S,4R)-di-tert-butyl 4-(benzyloxy)pyrrolidine-1,2-dicarboxylate 
• 886447-81-0 ethyl [4-[(4R)-benzyloxy-1-tert-butoxycarbonyl-(2S)-pyrrolidinylcarbonyl]-1-piperazinyl]acetate 
• 1238376-61-8 2-[(N-tert-butoxycarbonyl-4(R)-benzyloxy)-L-prolyl]1,2,3,4-tetrahydro-9H-pyrido[3,4-b ]indole 
• 1232834-99-9 (4R)-benzyloxy-(2S)-(N-methoxy-N-methylcarbamoyl)pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1403945-55-0 (2S,4R)-tert-butyl 4-(benzyloxy)-2-(3-bromo-2-(3,5-difluorophenylcarbamoyl)-1H-pyrrol-1-ylcarbamoyl)pyrrolidine-1-carboxylate 
• 176306-34-6 (2S,4S)-tert-butyl 4-(benzyloxy)-2-(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate 

Relevant articles and documents

DNA POLYMERASE THETA INHIBITORS

The invention relates to heterocyclic derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation.

HYDROXYPYRROLIDINE-SUBSTITUTED ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

Disclosed are compounds of Formula A, or a salt thereof: (A) Wherein "A1", R1, R2, R3, R6, and R7 are as defined herein, which compounds have properties for blocking Nav 1.7 ion channels fo

N-methyl-D-aspartate receptor modulators and methods of making and using same

Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.